Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population

Nav

General Info

Geography

China (CHN)

Hong Kong

Time period covered

01/2003 - 12/2008

Data type

Scientific literature

Keywords

Diarrhea, Diarrheal diseases, Rotavirus

Citation

Authors

Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, van Doorn LJ, Teoh YL, Tang H, Suryakiran PV, Smolenov IV, Bock HL, Han HH

Journal

Vaccine

Volume

Issue

Pages

4552-7

Publication year

2012

Suggested citation

Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, van Doorn LJ, Teoh YL, Tang H, Suryakiran PV, Smolenov IV, Bock HL, Han HH. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine. 2012; 30(30): 4552-7.

DOI

10.1016/j.vaccine.2012.03.030

PMID

22497874

GHDx Entry last modified on: Jan 31, 2024

Header sites

Search form

Main menu

Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population

Nav